These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23133854)

  • 1. Heart benefit of 'good' cholesterol depends on how it occurs.
    Mayo Clin Health Lett; 2012 Oct; 30(10):4. PubMed ID: 23133854
    [No Abstract]   [Full Text] [Related]  

  • 2. Exercise, C-reactive protein, and your heart.
    Harv Mens Health Watch; 2005 Jul; 9(12):1-4. PubMed ID: 16161240
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of disease: HDL metabolism as a target for novel therapies.
    Rader DJ
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):102-9. PubMed ID: 17245404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein metabolism: potential therapeutic targets.
    Davidson MH; Toth PP
    Am J Cardiol; 2007 Dec; 100(11 A):n32-40. PubMed ID: 18047851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL and heart attack.
    Harv Heart Lett; 2012 Nov; 23(3):8. PubMed ID: 23409309
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotinic acid and the prevention of coronary artery disease.
    Digby JE; Lee JM; Choudhury RP
    Curr Opin Lipidol; 2009 Aug; 20(4):321-6. PubMed ID: 19494772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?
    Brinton EA; Nanjee MN; Hopkins PN
    J Am Coll Cardiol; 2004 Jun; 43(12):2233-5. PubMed ID: 15193685
    [No Abstract]   [Full Text] [Related]  

  • 9. Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention.
    Parhofer KG
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):414-7. PubMed ID: 16151973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for aggressive lipid lowering: evidence from clinical trials.
    Farmer JA
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):305-9. PubMed ID: 15151477
    [No Abstract]   [Full Text] [Related]  

  • 12. High-density lipoprotein cholesterol as a therapeutic target to reduce cardiovascular events.
    Fonarow GC; Watson KE
    Am Heart J; 2004 Jun; 147(6):939-41. PubMed ID: 15199335
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and management of lipid disorders in children.
    Rocchini AP
    Heart Dis Stroke; 1994; 3(5):247-54. PubMed ID: 7820340
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperlipidemia and cardiovascular disease: should we abandon HDL cholesterol as a therapeutic target in coronary heart disease.
    Nofer JR
    Curr Opin Lipidol; 2010 Aug; 21(4):392-3. PubMed ID: 20625261
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-oxidants and coronary heart disease.
    Ubbink JB; Vermaak WJ
    S Afr Med J; 1995 Dec; 85(12):1279-81. PubMed ID: 8600584
    [No Abstract]   [Full Text] [Related]  

  • 16. [Increased triglycerides and/or low HDL cholesterol. A risk factor needing treatment?].
    Steinmetz A
    MMW Fortschr Med; 2002 Aug; 144(31-32):20-3. PubMed ID: 12422724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis: targeting endogenous apo A-I--a new approach for raising HDL.
    Shah PK
    Nat Rev Cardiol; 2011 Apr; 8(4):187-8. PubMed ID: 21364534
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel insights on high-density lipoprotein in coronary heart disease.
    Genest J
    Int J Clin Pract Suppl; 2002 Oct; (132):17-22. PubMed ID: 12425359
    [No Abstract]   [Full Text] [Related]  

  • 19. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
    Carlson LA
    Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
    [No Abstract]   [Full Text] [Related]  

  • 20. Focus on HDL as a therapeutic target for CAD risk reduction.
    Davidson MH
    Am J Cardiol; 2009 Nov; 104(10 Suppl):1E-2E. PubMed ID: 19895937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.